- Home
- RMTI vs RADX Comparison
RMTI vs RADX Comparison
Compare RMTI & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMTI
- RADX
- Stock Information
- Founded
- RMTI 1994
- RADX 2021
- Country
- RMTI United States
- RADX Australia
- Employees
- RMTI N/A
- RADX N/A
- Industry
- RMTI Biotechnology: Pharmaceutical Preparations
- RADX
- Sector
- RMTI Health Care
- RADX
- Exchange
- RMTI Nasdaq
- RADX NYSE
- Market Cap
- RMTI 32.5M
- RADX 32.5M
- IPO Year
- RMTI 1998
- RADX N/A
- Fundamental
- Price
- RMTI $1.02
- RADX $4.81
- Analyst Decision
- RMTI Strong Buy
- RADX Strong Buy
- Analyst Count
- RMTI 2
- RADX 3
- Target Price
- RMTI $4.00
- RADX $15.00
- AVG Volume (30 Days)
- RMTI 449.1K
- RADX 18.6K
- Earning Date
- RMTI 08-14-2025
- RADX 02-26-2025
- Dividend Yield
- RMTI N/A
- RADX N/A
- EPS Growth
- RMTI N/A
- RADX N/A
- EPS
- RMTI N/A
- RADX N/A
- Revenue
- RMTI $97,727,000.00
- RADX $204,609.00
- Revenue This Year
- RMTI N/A
- RADX N/A
- Revenue Next Year
- RMTI $11.16
- RADX N/A
- P/E Ratio
- RMTI N/A
- RADX N/A
- Revenue Growth
- RMTI 12.82
- RADX N/A
- 52 Week Low
- RMTI $0.78
- RADX $3.50
- 52 Week High
- RMTI $5.15
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- RMTI 48.28
- RADX N/A
- Support Level
- RMTI $1.08
- RADX N/A
- Resistance Level
- RMTI $1.18
- RADX N/A
- Average True Range (ATR)
- RMTI 0.09
- RADX 0.00
- MACD
- RMTI -0.01
- RADX 0.00
- Stochastic Oscillator
- RMTI 4.76
- RADX 0.00
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.